Who owns Valeant Pharmaceuticals Int?

Key details on Valeant Pharmaceuticals Int (Ticker: VRX)

Who owns Valeant Pharmaceuticals Int?

Is VRX a good stock to own? Find out who bought Valeant Pharmaceuticals Int, who sold Valeant Pharmaceuticals Int (VRX) stock, and who holds a large position in Valeant Pharmaceuticals Int.

Fund Name Number of Shares Share Valuation As Of
Ruane, Cunniff & Goldfarb 35.38M $3.60B Dec. 31, 2015
Nomura Holdings 25.74M $2.65B Dec. 31, 2015
T. Rowe Price Associates 21.85M $2.22B Dec. 31, 2015
Pershing Square Capital Management 16.59M $1.69B Dec. 31, 2015
ValueAct Holdings 14.99M $1.52B Dec. 31, 2015
Paulson & Co 13.27M $1.35B Dec. 31, 2015
SUSQUEHANNA INTERNATIONAL 13.15M $1.34B Dec. 31, 2015
Barclays 10.38M $1.05B Dec. 31, 2015
GOLDMAN SACHS 9.96M $1.01B Dec. 31, 2015
FMR 9.20M $934.61M Dec. 31, 2015
UBS Group AG 9.16M $931.42M Dec. 31, 2015
Grantham, Mayo, Van Otterloo & Co 8.18M $1.46B Sept. 30, 2015
HAP Trading 8.12M $74.42M Dec. 31, 2015
Brahman Capital 8.12M $825.17M Dec. 31, 2015
CIBC World Markets 7.80M $418.71M March 31, 2012
VIKING GLOBAL INVESTORS 7.79M $792.20M Dec. 31, 2015
JPMORGAN CHASE & CO 7.79M $792.43M Dec. 31, 2015
Blue Ridge Capital Holdings 7.52M $279.13M Sept. 30, 2011
Toronto-Dominion Bank 7.19M $909.50M June 30, 2014
Eagle Capital Management 7.03M $715.02M Dec. 31, 2015
Jackson Square Partners 6.47M $728.60M Dec. 31, 2015
BANK OF MONTREAL /CAN/ 6.43M $1.15B Sept. 30, 2015
Brave Warrior Advisors 6.25M $635.55M Dec. 31, 2015
D. E. Shaw & Co 6.04M $613.52M Dec. 31, 2015
Lone Pine Capital 5.83M $592.53M Dec. 31, 2015
Greystone Managed Investment 5.83M $311.84M March 31, 2012
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 5.69M $746.60M Sept. 30, 2014

Who sold Valeant Pharmaceuticals Int?

Fund Name Date Sold Number of Shares Sold Share Valuation
Royal Bank of Canada June 30, 2011 6.93M $360.24M
Iridian Asset Management June 30, 2011 5.69M $295.60M